U.S. Physical Therapy’s (NYSE:USPH) Q1 CY2026 Earnings Results: Revenue In Line With Expectations
U.S. Physical Therapy (NYSE: USPH) reported Q1 CY2026 earnings with revenue of $198.3 million, meeting analyst expectations, but a GAAP loss of $0.12 per share, significantly missing estimates. The company's adjusted EBITDA also fell below projections, and its operating margin decreased year-over-year. Despite these challenges, the company highlighted new initiatives aimed at improving efficiency and care, expecting them to bear fruit in the latter half of the year.
MAY 1·Stock Titan→
Vanguard reports 5.14% stake in US Physical Therapy (NASDAQ: USPH)
Vanguard Capital Management has disclosed a 5.14% stake in US Physical Therapy Inc. (NASDAQ: USPH), holding 777,590 shares of common stock. This is reported in a Schedule 13G filing, indicating a passive investment, with Vanguard having sole dispositive power over all shares and sole voting power over 113,528 shares. The filing's impact is deemed neutral as it does not signal active intent or changes in holdings.
MAR 4·Stock Titan▲
U.S. Physical Therapy (NYSE: USPH) lifts 2025 EBITDA and outlines hospital-driven growth
U.S. Physical Therapy (USPH) reported strong operating momentum in 2025, with adjusted EBITDA up 16.1% to $95 million, and expects 2026 adjusted EBITDA to be between $102 million and $106 million. The company achieved record clinic visit volumes despite Medicare rate cuts and saw significant growth in its injury prevention segment. USPH also announced two new long-term hospital affiliation agreements, projected to add at least $14 million to physical therapy revenue and $7.3 million to its adjusted EBITDA by 2027.
